Atea Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-EcoR1 Capital, LLC(8.4%),Oleg Nodelman(8.4%)等
02/14 20:08 (美東)
Atea Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-EcoR1 Capital, LLC(8.4%),Oleg Nodelman(8.4%)等
02/14 11:37 (美東)
Atea Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-EcoR1 Capital, LLC(8.4%),Oleg Nodelman(8.4%)等
02/14 09:17 (美東)
Atea Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(5.51%)
02/13 17:01 (美東)
Atea Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Jean-Pierre Sommadossi(9.6%),JPM Partners LLC(7.1%)
02/13 16:35 (美東)
Atea Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-FMR LLC(6.412%),Abigail P. Johnson(6.412%)
02/09 08:39 (美東)
Atea Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Braden M Leonard(6.7%),BML Investment Partners, L.P.(6.5%)
02/07 09:30 (美東)
Atea Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Braden M Leonard(6.7%),BML Investment Partners, L.P.(6.5%)
02/07 09:16 (美東)
Atea Pharmaceuticals | 4:持股變動聲明-高管 Corcoran Andrea
02/02 21:37 (美東)
Atea Pharmaceuticals | 4:持股變動聲明-高管 Sommadossi Jean-Pierre
02/02 21:32 (美東)
Atea Pharmaceuticals | 4:持股變動聲明-高管 Horga Maria Arantxa
02/02 21:32 (美東)
Atea Pharmaceuticals | 4:持股變動聲明-高管 Foster Wayne
02/02 21:31 (美東)
Atea Pharmaceuticals | 4:持股變動聲明-高管 Vavricka John
02/02 21:27 (美東)
Atea Pharmaceuticals | 4:持股變動聲明-高管 Hammond Janet MJ
02/02 21:27 (美東)
Atea Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(11.3%)
01/24 09:52 (美東)
Atea Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(4.8%),TANG CAPITAL MANAGEMENT, LLC(4.8%)等
2023/11/28 06:00 (美東)
Atea Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(10.6%)
2023/11/07 15:33 (美東)
Atea Pharmaceuticals | SC 13G:超過5%持股股東披露文件-BML Investment Partners, L.P.(5.0%)
2023/10/02 11:45 (美東)
Atea Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-FMR LLC(8.482%),Abigail P. Johnson(8.482%)
2023/09/11 08:23 (美東)
Atea Pharmaceuticals | 4:持股變動聲明-董事 Murphy Polly A.
2023/06/21 16:05 (美東)
暫無數據
暫無數據